22468 Results

People

  1. Ladanyi
    Ladanyi
  2. Antonescu
    Antonescu
  3. Offit
    Offit
  4. Solit
    Solit
  5. Levine
    Levine
  6. Berger
    Berger
  7. O'Reilly
    O'Reilly
  8. Cheung
    Cheung
  9. Reis-Filho
    Reis-Filho
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)
  7. Human Oncology and Pathogenesis Program (5697)
  8. Center for Hematologic Malignancies (5359)
  9. Center for Molecular Imaging and Biotechnology (5298)
  10. Department of Pathology and Laboratory Medicine (4773)
  1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biomarkers that predict sensitivity to heat shock protein 90 inhibitors (HSP90i)
    Meeting Abstract

    Jhaveri, K. L.; Iyengar, N. M.; Corben, A.; Patil, S.; Akram, M.; Towers, R.; Sakr, R.; Hudis, C.; King, T. A.; Rosen, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Defining the genetic basis of everolimus sensitivity in metastatic bladder cancer (MBC) by whole-genome sequencing (WGS)
    Meeting Abstract

    Iyer, G.; Milowsky, M. I.; Al-Ahmadie, H.; Hanrahan, A.; Janakiraman, M.; Heguy, A.; Viale, A.; Socci, N. D.; Sander, C.; Bochner, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Effect of IL-22 on intestinal stem cells, GVHD-related tissue damage, and GVL
    Meeting Abstract

    Hanash, A. M.; Van Den Brink, M. R. M.; Hua, G.; Kolesnick, R.; Blazar, B. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Reacquisition of RAI uptake in RAI-refractory metastatic thyroid cancers by pretreatment with the MEK inhibitor selumetinib
    Meeting Abstract

    Ho, A. L.; Leboeuf, R.; Grewal, R. K.; Sherman, E. J.; Deandreis, D.; Pentlow, K. S.; Tuttle, R. M.; Fury, M. G.; Ricarte-Filho, J. C. M.; Pfister, D. G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Hypersensitivity skin reactions in melanoma patients treated with vemurafenib after ipilimumab therapy
    Meeting Abstract

    Harding, J. J.; Lacouture, M. E.; Pulitzer, M.; Callahan, M.; Postow, M. A.; Carvajal, R. D.; Wolchok, J. D.; Chapman, P. B.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Ipilimumab (Ipi) expanded access program (EAP) for patients (pts) with stage III/IV melanoma: 10 mg/kg cohort interim results
    Meeting Abstract

    Hamid, O.; Hwu, W. J.; Richards, J. M.; Weber, J. S.; Wolchok, J. D.; Sznol, M.; Minor, D. R.; Pavlick, A. C.; Urba, W. J.; Hodi, F. S.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Evaluation of FDG-PET in pretreatment staging in locally advanced rectal cancer: A prospective study
    Meeting Abstract

    Guillem, J. G.; Ruby, J. A.; Leibold, T.; Akhurst, T. J.; Larson, S. M.; Gollub, M.; Ginsberg, M. S.; Saltz, L.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Surgery for patients receiving ipilimumab: Safety profile and immunological insights
    Meeting Abstract

    Gyorki, D. E.; Yuan, J.; Mu, Z.; Zaidi, B.; Gallardo, H. F.; Brady, M. S.; Gutin, P. H.; Coit, D. G.; Wolchok, J. D.; Ariyan, C. E.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A comprehensive analysis of BRAF and KRAS mutation status in low-grade serous (LGS) and serous borderline (SB) ovarian cancer (OC)
    Meeting Abstract

    Grisham, R. N.; Garg, K.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Hyman, D. M.; Levine, D. A.; Solit, D. B.; Aghajanian, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Prospective evaluation of serial 2-hydroxyglutarate in acute myeloid leukemia (AML) to determine response to therapy and predict relapse
    Meeting Abstract

    Fathi, A. T.; Abdel-Wahab, O. I.; Sadrzadeh, H.; Foster, J.; Burke, M.; Borger, D. R.; Iafrate, A. J.; Adamia, S.; Liu, S.; Ballen, K. K.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save